Vanguard Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103M | Sell |
|
|||||
|
2025
Q1 | $135M | Buy |
|
|||||
|
2024
Q4 | $235M | Buy |
|
|||||
|
2024
Q3 | $207M | Sell |
|
|||||
|
2024
Q2 | $196M | Sell |
|
|||||
|
2024
Q1 | $223M | Buy |
|
|||||
|
2023
Q4 | $229M | Sell |
|
|||||
|
2023
Q3 | $176M | Sell |
|
|||||
|
2023
Q2 | $235M | Buy |
|
|||||
|
2023
Q1 | $241M | Buy |
|
|||||
|
2022
Q4 | $126M | Buy |
|
|||||
|
2022
Q3 | $113M | Sell |
|
|||||
|
2022
Q2 | $109M | Buy |
|
|||||
|
2022
Q1 | $158M | Buy |
|
|||||
|
2021
Q4 | $439M | Buy |
|
|||||
|
2021
Q3 | $611M | Buy |
|
|||||
|
2021
Q2 | $551M | Buy |
|
|||||
|
2021
Q1 | $580M | Buy |
|
|||||
|
2020
Q4 | $601M | Buy |
|
|||||
|
2020
Q3 | $401M | Sell |
|
|||||
|
2020
Q2 | $348M | Buy |
|
|||||
|
2020
Q1 | $298M | Buy |
|
|||||
|
2019
Q4 | $308M | Buy |
|
|||||
|
2019
Q3 | $199M | Buy |
|
|||||
|
2019
Q2 | $179M | Buy |
|
|||||
|
2019
Q1 | $118M | Buy |
|
|||||
|
2018
Q4 | $51.6M | Buy |
|
|||||
|
2018
Q3 | $58.9M | Buy |
|
|||||
|
2018
Q2 | $40.6M | Buy |
|
|||||
|
2018
Q1 | $25M | Buy |
|
|||||
|
2017
Q4 | $26.2M | Buy |
|
|||||
|
2017
Q3 | $32.1M | Buy |
|
|||||
|
2017
Q2 | $24.4M | Buy |
|
|||||
|
2017
Q1 | $21.1M | Buy |
|
|||||
|
2016
Q4 | $21.5M | Buy |
|
|||||
|
2016
Q3 | $18.6M | Buy |
|
|||||
|
2016
Q2 | $17.1M | Buy |
|
|||||
|
2016
Q1 | $11.4M | Buy |
|
|||||
|
2015
Q4 | $12.6M | Buy |
|
|||||
|
2015
Q3 | $9.01M | Buy |
|
|||||
|
2015
Q2 | $7.76M | Buy |
|
|||||
|
2015
Q1 | $6.12M | Buy |
|
|||||
|
2014
Q4 | $4.98M | Buy |
|
|||||
|
2014
Q3 | $6.09M | Buy |
|
|||||
|
2014
Q2 | $2.6M | Sell |
|
|||||
|
2014
Q1 | $2.89M | Buy |
|
|||||
|
2013
Q4 | $2.47M | Buy |
|
|||||
|
2013
Q3 | $2.04M | Buy |
|
|||||
|
2013
Q2 | $1.55M | Buy |
|